{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:57:24Z","timestamp":1781614644570,"version":"3.54.5"},"reference-count":175,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"unspecified","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"A&D Instruments, Ltd.","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"IQAir AG","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"PremaLabs Diagnostics, Ltd.","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Lansion Biotechnology, Co. Ltd.","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,5,29]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Inflammation is causally related to cancer progression and cardiovascular toxicities of anticancer treatments. Fine particulate matter (PM\n                      <jats:sub>2.5<\/jats:sub>\n                      ) air filtration lowers interleukin-6 and C reactive protein (CRP) levels in high-risk cardiopulmonary groups, though potential synergistic or confounding effects with routine medications\u2014statins, cyclo-oxygenase-2 inhibitors, beta-blockers\u2014remain poorly understood. Whether overnight in-bedroom PM\n                      <jats:sub>2.5<\/jats:sub>\n                      air filtration effectively reduces inflammation and prothrombotic biomarkers in survivors of adult-onset cancer at high cardiovascular toxicity risk is unknown.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      BREATHS is a series of randomised, adaptive, blinded, placebo-controlled N-of-1 trials conducted in densely populated urban areas of Valencia, Spain, during winter when PM\n                      <jats:sub>2.5<\/jats:sub>\n                      concentrations historically exceed WHO guidelines. Eligible participants are aged \u226518 years with a history of breast, colorectal, prostate, lung or haematological cancer, prior cardiotoxic cancer therapy and CRP \u22653\u2009mg\/L. Each participant will undergo up to three cycles, each comprising two 14-day periods of advanced submicron air filtration (clean air delivery rate: 275 m\n                      <jats:sup>3<\/jats:sup>\n                      \/hour nightly) or placebo (sham filtration), in random order. Sequence duration ranges from 4 weeks to 12 weeks, depending on whether a clinically meaningful CRP reduction (&lt;2\u2009mg\/L or \u226535% relative to placebo) is achieved during active treatment of each cycle. Non-responders will enter an open-label phase (OLP) of two 14-day periods: no treatment followed by continuous filtration. The primary endpoint is change in CRP between active and placebo phases. Secondary endpoints include changes in serum amyloid A, haemoglobin A1c and blood pressure. Indoor and outdoor particulate exposure will be quantified using paired real-time monitors at each home.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial protocol was approved by the research ethics committees of University College London (REC UCL: 22105\/001), Doctor Peset University Hospital (CEIm: 044\/25) and General University Hospital of Valencia (CEIm: 1\/2026 EO-PS), Spain. Results will be presented at relevant conferences and published in peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06778122\">NCT06778122<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-111748","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:25:38Z","timestamp":1781612738000},"page":"e111748","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["In-bedroom renewed air as anti-inflammatory adjuvant therapy in cancer survivors: protocol for the randomised, placebo-controlled BREATHS N-of-1 trial series"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06778122","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06778122","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4492-2747","authenticated-orcid":false,"given":"Eva","family":"Hernandez-Garcia","sequence":"first","affiliation":[{"name":"The Bartlett School of Sustainable Construction, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Edkins","sequence":"additional","affiliation":[{"name":"The Bartlett School of Sustainable Construction, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Chrysikou","sequence":"additional","affiliation":[{"name":"The Bartlett School of Sustainable Construction, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8965-104X","authenticated-orcid":false,"given":"Jos\u00e9 M","family":"Ord\u00f3\u00f1ez-Mena","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Nekhlyudov","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juyong Brian","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R","family":"McLean","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Frost","sequence":"additional","affiliation":[{"name":"Cancer Research UK National Biomarker Centre, Digital Cancer Research Team, The University of Manchester, Manchester, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Panigrahy","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"2026061605251552000_16.6.e111748.1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1591"},{"key":"2026061605251552000_16.6.e111748.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.23130"},{"key":"2026061605251552000_16.6.e111748.3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23025","article-title":"Assessment of Second Primary Cancer Risk Among Men Receiving Primary Radiotherapy vs Surgery for the Treatment of Prostate Cancer","volume":"5","author":"Bagshaw","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026061605251552000_16.6.e111748.4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/cncr.33981","article-title":"Chronic comorbid conditions among adult cancer survivors in the United States: Results from the National Health Interview Survey, 2002-2018","volume":"128","author":"Jiang","year":"2022","journal-title":"Cancer"},{"key":"2026061605251552000_16.6.e111748.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00242-2"},{"key":"2026061605251552000_16.6.e111748.6","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.01736"},{"key":"2026061605251552000_16.6.e111748.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.04.042"},{"key":"2026061605251552000_16.6.e111748.8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaccao.2022.01.100","article-title":"Incident Cardiovascular Disease Among Adults With Cancer: A Population-Based Cohort Study","volume":"4","author":"Paterson","year":"2022","journal-title":"JACC CardioOncol"},{"key":"2026061605251552000_16.6.e111748.9","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1002\/cam4.2657","article-title":"Incidence rates of cardiovascular outcomes in a community-based population of cancer patients","volume":"8","author":"Masson","year":"2019","journal-title":"Cancer Med"},{"key":"2026061605251552000_16.6.e111748.10","article-title":"Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathy","volume":"6","author":"Canada","year":"2020","journal-title":"Cardiooncology"},{"key":"2026061605251552000_16.6.e111748.11","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"The Lancet"},{"key":"2026061605251552000_16.6.e111748.12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/jth.13975","article-title":"Coagulation and inflammation in long-term cancer survivors: results from the adult population","volume":"16","author":"Panova-Noeva","year":"2018","journal-title":"J Thromb Haemost"},{"key":"2026061605251552000_16.6.e111748.13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.9068"},{"key":"2026061605251552000_16.6.e111748.14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.054718"},{"key":"2026061605251552000_16.6.e111748.15","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41416-021-01458-y","article-title":"Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patients","volume":"125","author":"Hua","year":"2021","journal-title":"Br J Cancer"},{"key":"2026061605251552000_16.6.e111748.16","doi-asserted-by":"crossref","first-page":"104866","DOI":"10.1016\/j.psyneuen.2020.104866","article-title":"Within-person changes in cancer-related distress predict breast cancer survivors\u2019 inflammation across treatment","volume":"121","author":"Renna","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"2026061605251552000_16.6.e111748.17","doi-asserted-by":"crossref","unstructured":"Bower JE , Ganz PA , Irwin MR , et al . Acute and Chronic Effects of Adjuvant Therapy on Inflammatory Markers in Breast Cancer Patients. JNCI Cancer Spectr 2022;6. doi:10.1093\/jncics\/pkac052","DOI":"10.1093\/jncics\/pkac052"},{"key":"2026061605251552000_16.6.e111748.18","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-022-00807-y","article-title":"Metabolic syndrome and breast cancer survivors: a follow-up analysis after completion of chemotherapy","volume":"14","author":"Dieli-Conwright","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"2026061605251552000_16.6.e111748.19","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.868137","article-title":"Post-Treatment Plasma D-Dimer Levels Are Associated With Short-Term Outcomes in Patients With Cancer-Associated Stroke","volume":"13","author":"Nakajima","year":"2022","journal-title":"Front Neurol"},{"key":"2026061605251552000_16.6.e111748.20","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/jth.14774","article-title":"Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: A prospective study","volume":"18","author":"Posch","year":"2020","journal-title":"J Thromb Haemost"},{"key":"2026061605251552000_16.6.e111748.21","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-012-2039-z"},{"key":"2026061605251552000_16.6.e111748.22","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1111\/bcp.15356","article-title":"Plasma levels of VEGF-A and VCAM-1 as predictors of drug-induced hypertension in patients treated with VEGF pathway inhibitors","volume":"88","author":"Quintanilha","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"2026061605251552000_16.6.e111748.23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01738"},{"key":"2026061605251552000_16.6.e111748.24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2018-000591","article-title":"Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes","volume":"7","author":"Kotwal","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026061605251552000_16.6.e111748.25","doi-asserted-by":"publisher","DOI":"10.2337\/db18-1471-P"},{"key":"2026061605251552000_16.6.e111748.26","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/cncr.31389","article-title":"Polypharmacy and patterns of prescription medication use among cancer survivors","volume":"124","author":"Murphy","year":"2018","journal-title":"Cancer"},{"key":"2026061605251552000_16.6.e111748.27","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1161\/CIR.0000000000001056","article-title":"Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association","volume":"145","author":"Beavers","year":"2022","journal-title":"Circulation"},{"key":"2026061605251552000_16.6.e111748.28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s11764-021-01059-x","article-title":"Polypharmacy and medication use by cancer history in a nationally representative group of adults in the USA, 2003-2014","volume":"16","author":"Hsu","year":"2022","journal-title":"J Cancer Surviv"},{"key":"2026061605251552000_16.6.e111748.29","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jamaoncol.2021.2193","article-title":"Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial","volume":"7","author":"Coombes","year":"2021","journal-title":"JAMA Oncol"},{"key":"2026061605251552000_16.6.e111748.30","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy017"},{"key":"2026061605251552000_16.6.e111748.31","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/jama.2021.2454","article-title":"Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB\/SWOG 80702 (Alliance) Randomized Clinical Trial","volume":"325","author":"Meyerhardt","year":"2021","journal-title":"JAMA"},{"key":"2026061605251552000_16.6.e111748.32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.3743"},{"key":"2026061605251552000_16.6.e111748.33","doi-asserted-by":"crossref","first-page":"360922","DOI":"10.1200\/JCO.2022.40.36_suppl.360922","article-title":"A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial","volume":"40","author":"Chen","year":"2022","journal-title":"J Clin Oncol"},{"key":"2026061605251552000_16.6.e111748.34","doi-asserted-by":"publisher","DOI":"10.1200\/Jco.18.00636"},{"key":"2026061605251552000_16.6.e111748.35","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-10-0403"},{"key":"2026061605251552000_16.6.e111748.36","first-page":"302","article-title":"Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function","volume":"31","author":"Chotenimitkhun","year":"2015","journal-title":"Can J Cardiol"},{"key":"2026061605251552000_16.6.e111748.37","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.11887"},{"key":"2026061605251552000_16.6.e111748.38","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvad031"},{"key":"2026061605251552000_16.6.e111748.39","doi-asserted-by":"crossref","unstructured":"Hundley WG , D\u2019Agostino R , Crotts T , et al . Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment. NEJM Evid 2022;1. doi:10.1056\/evidoa2200097","DOI":"10.1056\/EVIDoa2200097"},{"key":"2026061605251552000_16.6.e111748.40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1074248418821721","article-title":"Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial","volume":"24","author":"Nabati","year":"2019","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2026061605251552000_16.6.e111748.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.05.025"},{"key":"2026061605251552000_16.6.e111748.42","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00228-020-02967-0","article-title":"Efficacy and safety profile of statins in patients with cancer: a systematic review of randomised controlled trials","volume":"76","author":"Thomas","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"2026061605251552000_16.6.e111748.43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0480"},{"key":"2026061605251552000_16.6.e111748.44","doi-asserted-by":"crossref","first-page":"i68","DOI":"10.1093\/bja\/aet577","article-title":"Association between preoperative glucocorticoids and long-term survival and cancer recurrence after colectomy: follow-up analysis of a previous randomized controlled trial","volume":"113 Suppl 1","author":"Singh","year":"2014","journal-title":"Br J Anaesth"},{"key":"2026061605251552000_16.6.e111748.45","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1283"},{"key":"2026061605251552000_16.6.e111748.46","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.0006"},{"key":"2026061605251552000_16.6.e111748.47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaccao.2022.01.101","article-title":"The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review","volume":"4","author":"Omland","year":"2022","journal-title":"JACC CardioOncol"},{"key":"2026061605251552000_16.6.e111748.48","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7049","article-title":"Cardiovascular\/anti\u2010inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta\u2010analysis of randomized trials","volume":"13","author":"Benjamin","year":"2024","journal-title":"Cancer Med"},{"key":"2026061605251552000_16.6.e111748.49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jaccao.2024.04.003","article-title":"Air Pollution in Cardio-Oncology and Unraveling the Environmental Nexus: JACC: CardioOncology State-of-the-Art Review","volume":"6","author":"Zhu","year":"2024","journal-title":"JACC CardioOncol"},{"key":"2026061605251552000_16.6.e111748.50","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3390\/ijerph16061081","article-title":"Fine Particulate Matter and Respiratory Healthcare Encounters among Survivors of Childhood Cancers","volume":"16","author":"Ou","year":"2019","journal-title":"IJERPH"},{"key":"2026061605251552000_16.6.e111748.51","doi-asserted-by":"crossref","unstructured":"Coleman NC , Ezzati M , Marshall JD , et al . Fine Particulate Matter Air Pollution and Mortality Risk Among US Cancer Patients and Survivors. JNCI Cancer Spectrum 2021;5. doi:10.1093\/jncics\/pkab001","DOI":"10.1093\/jncics\/pkab001"},{"key":"2026061605251552000_16.6.e111748.52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ecoenv.2019.02.064","article-title":"Fine particulate matter-induced cardiovascular injury is associated with NLRP3 inflammasome activation in Apo E-\/- mice","volume":"174","author":"Du","year":"2019","journal-title":"Ecotoxicol Environ Saf"},{"key":"2026061605251552000_16.6.e111748.53","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/cns.13837","article-title":"Fine particulate matter exposure aggravates ischemic injury via NLRP3 inflammasome activation and pyroptosis","volume":"28","author":"Gao","year":"2022","journal-title":"CNS Neurosci Ther"},{"key":"2026061605251552000_16.6.e111748.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2023.122997"},{"key":"2026061605251552000_16.6.e111748.55","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/all.16521","article-title":"Particulate Matter 2.5 Aggravates Airway Inflammation by Neutrophil\u2010Mediated Inflammasome Activation","volume":"80","author":"Chen","year":"2025","journal-title":"Allergy"},{"key":"2026061605251552000_16.6.e111748.56","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1039\/C5TX00351B","article-title":"Fine particulate matter induces vascular endothelial activation via IL-6 dependent JAK1\/STAT3 signaling pathway","volume":"5","author":"Hu","year":"2016","journal-title":"Toxicol Res"},{"key":"2026061605251552000_16.6.e111748.57","first-page":"3967","article-title":"COX-2 mediates PM2.5-induced apoptosis and inflammation in vascular endothelial cells","volume":"9","author":"Yin","year":"2017","journal-title":"Am J Transl Res"},{"key":"2026061605251552000_16.6.e111748.58","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1161\/HYPERTENSIONAHA.123.21410","article-title":"Particulate Air Pollution and Blood Pressure: Signaling by the Arachidonate Metabolism","volume":"80","author":"Wang","year":"2023","journal-title":"Hypertension"},{"key":"2026061605251552000_16.6.e111748.59","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1007\/s10753-020-01269-y","article-title":"PM2.5 Exposure Induces Inflammatory Response in Macrophages via the TLR4\/COX-2\/NF-\u03baB Pathway","volume":"43","author":"Fu","year":"2020","journal-title":"Inflammation"},{"key":"2026061605251552000_16.6.e111748.60","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/CIRCRESAHA.124.324411","article-title":"Exposure to Fine Particulate Matter Air Pollution Disrupts Erythrocyte Turnover","volume":"134","author":"Asplund","year":"2024","journal-title":"Circ Res"},{"key":"2026061605251552000_16.6.e111748.61","doi-asserted-by":"crossref","unstructured":"Tong H , Zhang S , Chen H , et al . Abstract 14863: Omega-3 Fatty Acids Intake and Oxylipins Production in Response to Short-Term Ambient Air Pollution Exposure in Healthy Adults. Circulation 2023;148. doi:10.1161\/circ.148.suppl_1.14863","DOI":"10.1161\/circ.148.suppl_1.14863"},{"key":"2026061605251552000_16.6.e111748.62","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pharmthera.2019.02.001","article-title":"Quenching the fires: Pro-resolving mediators, air pollution, and smoking","volume":"197","author":"Thatcher","year":"2019","journal-title":"Pharmacol Ther"},{"key":"2026061605251552000_16.6.e111748.63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1804000116"},{"key":"2026061605251552000_16.6.e111748.64","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170681"},{"key":"2026061605251552000_16.6.e111748.65","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.trecan.2020.01.018","article-title":"Dark Side of Cytotoxic Therapy: Chemoradiation-Induced Cell Death and Tumor Repopulation","volume":"6","author":"Jiang","year":"2020","journal-title":"Trends Cancer"},{"key":"2026061605251552000_16.6.e111748.66","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-024-02131-5"},{"key":"2026061605251552000_16.6.e111748.67","doi-asserted-by":"crossref","first-page":"107879","DOI":"10.1016\/j.pharmthera.2021.107879","article-title":"Resolution of inflammation: An organizing principle in biology and medicine","volume":"227","author":"Panigrahy","year":"2021","journal-title":"Pharmacology & Therapeutics"},{"key":"2026061605251552000_16.6.e111748.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107670"},{"key":"2026061605251552000_16.6.e111748.69","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1161\/ATVBAHA.124.321058","article-title":"One-Year Effects of High-Intensity Statin on Bioactive Lipids: Findings From the JUPITER Trial","volume":"44","author":"Hoshi","year":"2024","journal-title":"ATVB"},{"key":"2026061605251552000_16.6.e111748.70","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.307308"},{"key":"2026061605251552000_16.6.e111748.71","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13505"},{"key":"2026061605251552000_16.6.e111748.72","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12491"},{"key":"2026061605251552000_16.6.e111748.73","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.164"},{"key":"2026061605251552000_16.6.e111748.74","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n1537","article-title":"Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses","volume":"374","author":"Cai","year":"2021","journal-title":"BMJ"},{"key":"2026061605251552000_16.6.e111748.75","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061476","article-title":"Metabolic adverse events associated with systemic corticosteroid therapy\u2014a systematic review and meta-analysis","volume":"12","author":"Kulkarni","year":"2022","journal-title":"BMJ Open"},{"key":"2026061605251552000_16.6.e111748.76","article-title":"Statin Modulation of Human T-Cell Proliferation, IL-1\u03b2 and IL-17 Production, and IFN-\u03b3 T Cell Expression: Synergy with Conventional Immunosuppressive Agents","volume":"2013","author":"Jameel","year":"2013","journal-title":"Int J Inflam"},{"key":"2026061605251552000_16.6.e111748.77","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97943"},{"key":"2026061605251552000_16.6.e111748.78","doi-asserted-by":"crossref","DOI":"10.4209\/aaqr.230202","article-title":"Real-World Effectiveness of Portable Air Cleaners in Reducing Home Particulate Matter Concentrations","volume":"24","author":"Lu","year":"2024","journal-title":"Aerosol Air Qual Res"},{"key":"2026061605251552000_16.6.e111748.79","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamapediatrics.2020.0140","article-title":"Association Between Bedroom Particulate Matter Filtration and Changes in Airway Pathophysiology in Children With Asthma","volume":"174","author":"Cui","year":"2020","journal-title":"JAMA Pediatr"},{"key":"2026061605251552000_16.6.e111748.80","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.3308"},{"key":"2026061605251552000_16.6.e111748.81","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.026796"},{"key":"2026061605251552000_16.6.e111748.82","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.jacc.2020.10.020","article-title":"Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations","volume":"76","author":"Newman","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026061605251552000_16.6.e111748.83","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182010891","article-title":"The Interplay between Housing Environmental Attributes and Design Exposures and Psychoneuroimmunology Profile-An Exploratory Review and Analysis Paper in the Cancer Survivors\u2019 Mental Health Morbidity Context","volume":"18","author":"Hernandez-Garcia","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2026061605251552000_16.6.e111748.84","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.scitotenv.2017.06.095","article-title":"Cardiorespiratory responses of air filtration: A randomized crossover intervention trial in seniors living in Beijing","volume":"603\u2013604","author":"Shao","year":"2017","journal-title":"Science of The Total Environment"},{"key":"2026061605251552000_16.6.e111748.85","doi-asserted-by":"publisher","DOI":"10.1186\/1476-069X-12-116"},{"key":"2026061605251552000_16.6.e111748.86","doi-asserted-by":"crossref","first-page":"1082327","DOI":"10.3389\/fpubh.2022.1082327","article-title":"Cardiovascular benefits of air purifier in patients with stable coronary artery disease: A randomized single-blind crossover study","volume":"10","author":"Liu","year":"2022","journal-title":"Front Public Health"},{"key":"2026061605251552000_16.6.e111748.87","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3349\/ymj.2020.61.8.689","article-title":"Effects of Air Purifiers on Patients with Allergic Rhinitis: a Multicenter, Randomized, Double-Blind, and Placebo-Controlled Study","volume":"61","author":"Park","year":"2020","journal-title":"Yonsei Med J"},{"key":"2026061605251552000_16.6.e111748.88","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12989-022-00451-4","article-title":"Omega-3 fatty acids attenuate cardiovascular effects of short-term exposure to ambient air pollution","volume":"19","author":"Chen","year":"2022","journal-title":"Part Fibre Toxicol"},{"key":"2026061605251552000_16.6.e111748.89","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01519-y"},{"key":"2026061605251552000_16.6.e111748.90","doi-asserted-by":"publisher","DOI":"10.1038\/520609a"},{"key":"2026061605251552000_16.6.e111748.91","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1002\/cncr.32376","article-title":"Is cancer prevention influenced by the built environment? A multidisciplinary scoping review","volume":"125","author":"Wray","year":"2019","journal-title":"Cancer"},{"key":"2026061605251552000_16.6.e111748.92","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-1588"},{"key":"2026061605251552000_16.6.e111748.93","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"2026061605251552000_16.6.e111748.94","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1738","article-title":"CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement","volume":"350","author":"Vohra","year":"2015","journal-title":"BMJ"},{"key":"2026061605251552000_16.6.e111748.95","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0046"},{"key":"2026061605251552000_16.6.e111748.96","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m122","article-title":"SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist","volume":"368","author":"Porcino","year":"2020","journal-title":"BMJ"},{"key":"2026061605251552000_16.6.e111748.97","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081477","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomised trials","volume":"389","author":"Chan","year":"2025","journal-title":"BMJ"},{"key":"2026061605251552000_16.6.e111748.98","doi-asserted-by":"crossref","first-page":"054072","DOI":"10.1088\/1748-9326\/abe435","article-title":"Assessment of an air quality surveillance network through passive pollution measurement with mobile sensors","volume":"16","author":"Lorenzo-S\u00e1ez","year":"2021","journal-title":"Environ Res Lett"},{"key":"2026061605251552000_16.6.e111748.99","unstructured":"IQAir . Valencia air quality data. 2023. Available: https:\/\/www.iqair.com\/gb\/spain\/valencia\/valencia"},{"key":"2026061605251552000_16.6.e111748.100","article-title":"Evaluaci\u00f3n del impacto en mortalidad de la contaminaci\u00f3n del aire por part\u00edculas en la ciudad de Val\u00e8ncia en el periodo 2015-2017 [Assessment of the impact on mortality of air pollution by particles in the city of Valencia during the period 2015-2017]","volume":"98","author":"L\u00f3pez Fern\u00e1ndez","year":"2024","journal-title":"Rev Esp Salud Publica"},{"key":"2026061605251552000_16.6.e111748.101","unstructured":"WHO global air quality guidelines . Particulate matter (pm2.5 and pm10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide. 2021."},{"key":"2026061605251552000_16.6.e111748.102","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jamacardio.2023.3558","article-title":"Cardio-Oncology Rehabilitation for Cancer Survivors With High Cardiovascular Risk","volume":"8","author":"Viamonte","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2026061605251552000_16.6.e111748.103","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac244"},{"key":"2026061605251552000_16.6.e111748.104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035254","article-title":"Predicting Anatomical Therapeutic Chemical (ATC) Classification of Drugs by Integrating Chemical-Chemical Interactions and Similarities","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"key":"2026061605251552000_16.6.e111748.105","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archinternmed.2012.3712","article-title":"Within-person variability in high-sensitivity C-reactive protein","volume":"172","author":"Bower","year":"2012","journal-title":"Arch Intern Med"},{"key":"2026061605251552000_16.6.e111748.106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060759","article-title":"Time variability of C-reactive protein: implications for clinical risk stratification","volume":"8","author":"Bogaty","year":"2013","journal-title":"PLoS ONE"},{"key":"2026061605251552000_16.6.e111748.107","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000052939.59093.45"},{"key":"2026061605251552000_16.6.e111748.108","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11869-022-01288-8","article-title":"Exposure to fine particulate matter (PM2.5) from non-tobacco sources in homes within high-income countries: a systematic review","volume":"16","author":"Wei","year":"2023","journal-title":"Air Qual Atmos Health"},{"key":"2026061605251552000_16.6.e111748.109","doi-asserted-by":"crossref","first-page":"109359","DOI":"10.1016\/j.buildenv.2022.109359","article-title":"Assessing the contributions of outdoor and indoor sources to air quality in London homes of the SCAMP cohort","volume":"222","author":"Vu","year":"2022","journal-title":"Build Environ"},{"key":"2026061605251552000_16.6.e111748.110","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.5194\/essd-15-4713-2023","article-title":"HISDAC-ES: historical settlement data compilation for Spain (1900\u20132020)","volume":"15","author":"Uhl","year":"2023","journal-title":"Earth Syst Sci Data"},{"key":"2026061605251552000_16.6.e111748.111","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2308832120","article-title":"Assessing residential PM2.5 concentrations and infiltration factors with high spatiotemporal resolution using crowdsourced sensors","volume":"120","author":"Lunderberg","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026061605251552000_16.6.e111748.112","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/jamaoto.2019.3744","article-title":"Importance of Defining and Interpreting a Clinically Meaningful Difference in Clinical Research","volume":"146","author":"Kallogjeri","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026061605251552000_16.6.e111748.113","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-13-0852"},{"key":"2026061605251552000_16.6.e111748.114","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2020.07.005"},{"key":"2026061605251552000_16.6.e111748.115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.11.037"},{"key":"2026061605251552000_16.6.e111748.116","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4641-x","article-title":"RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer \u2013 the S.U.R.G.U.V.A.N.T. trial","volume":"18","author":"Redmond","year":"2018","journal-title":"BMC Cancer"},{"key":"2026061605251552000_16.6.e111748.117","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S2468-1253(19)30289-4","article-title":"Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial","volume":"4","author":"Joharatnam-Hogan","year":"2019","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"2026061605251552000_16.6.e111748.118","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807646"},{"key":"2026061605251552000_16.6.e111748.119","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1410489"},{"key":"2026061605251552000_16.6.e111748.120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"The Lancet"},{"key":"2026061605251552000_16.6.e111748.121","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021177","article-title":"Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive Protein","volume":"25","author":"Stute","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026061605251552000_16.6.e111748.122","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13121","article-title":"Ratio of serum amyloid A to C-reactive protein is constant in the same patients but differs greatly between patients with inflammatory diseases","volume":"95","author":"Saiki","year":"2022","journal-title":"Scand J Immunol"},{"key":"2026061605251552000_16.6.e111748.123","doi-asserted-by":"publisher","DOI":"10.1097\/mol.0000000000000616"},{"key":"2026061605251552000_16.6.e111748.124","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000077","article-title":"Hemoglobin a1c is associated with increased risk of incident coronary heart disease among apparently healthy, nondiabetic men and women","volume":"2","author":"Pai","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026061605251552000_16.6.e111748.125","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000199034.26345.bc"},{"key":"2026061605251552000_16.6.e111748.126","article-title":"Baseline blood pressure and development of cardiotoxicity in patients treated with anthracyclines: A systematic review","volume":"15","author":"Philip","year":"2022","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"2026061605251552000_16.6.e111748.127","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad814"},{"key":"2026061605251552000_16.6.e111748.128","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2018-205688"},{"key":"2026061605251552000_16.6.e111748.129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267516","article-title":"Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system","volume":"18","author":"Calarco","year":"2023","journal-title":"PLoS ONE"},{"key":"2026061605251552000_16.6.e111748.130","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0040"},{"key":"2026061605251552000_16.6.e111748.131","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10122149","article-title":"Rapid Quantification of SARS-CoV-2 Neutralising Antibodies Using Time-Resolved Fluorescence Immunoassay","volume":"10","author":"McLean","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2026061605251552000_16.6.e111748.132","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/HJH.0000000000002843","article-title":"2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement","volume":"39","author":"Stergiou","year":"2021","journal-title":"J Hypertens"},{"key":"2026061605251552000_16.6.e111748.133","unstructured":"European Society of Hypertension IsoHWHL . Validated devices for home blood pressure monitoring. 2023."},{"key":"2026061605251552000_16.6.e111748.134","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32831b9e6b"},{"key":"2026061605251552000_16.6.e111748.135","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmr113"},{"key":"2026061605251552000_16.6.e111748.136","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jaccao.2019.11.009","article-title":"Hypertension in Cancer Patients and Survivors: Epidemiology, Diagnosis, and Management","volume":"1","author":"Cohen","year":"2019","journal-title":"JACC CardioOncol"},{"key":"2026061605251552000_16.6.e111748.137","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmi027"},{"key":"2026061605251552000_16.6.e111748.138","unstructured":"(MDCG) MDCG . MDCG 2021-24 - Guidance on Classification of Medical Devices. European Commission, 2021."},{"key":"2026061605251552000_16.6.e111748.139","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-015-0045-7","article-title":"The use of the Godin-Shephard Leisure-Time Physical Activity Questionnaire in oncology research: a systematic review","volume":"15","author":"Amireault","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"2026061605251552000_16.6.e111748.140","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.7.713"},{"key":"2026061605251552000_16.6.e111748.141","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.113.063602"},{"key":"2026061605251552000_16.6.e111748.142","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114509993837"},{"key":"2026061605251552000_16.6.e111748.143","doi-asserted-by":"crossref","unstructured":"Estruch R , Ros E , Salas-Salvad\u00f3 J , et al . Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med 2018;378. doi:10.1056\/NEJMoa1800389","DOI":"10.1056\/NEJMoa1800389"},{"key":"2026061605251552000_16.6.e111748.144","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(89)90047-4"},{"key":"2026061605251552000_16.6.e111748.145","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jes.7500490"},{"key":"2026061605251552000_16.6.e111748.146","unstructured":"Sample size calculations for n-of-1 trials. arXiv Preprint arXiv 2021;211008970. doi:10.48550\/arXiv.2110.08970"},{"key":"2026061605251552000_16.6.e111748.147","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(96)00429-5"},{"key":"2026061605251552000_16.6.e111748.148","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"2026061605251552000_16.6.e111748.149","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkac054","article-title":"Sustained Mild Inflammation in Cancer Survivors: Where to from Here?","volume":"6","author":"Walker","year":"2022","journal-title":"JNCI Cancer Spectr"},{"key":"2026061605251552000_16.6.e111748.150","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.03.067"},{"key":"2026061605251552000_16.6.e111748.151","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0405445101"},{"key":"2026061605251552000_16.6.e111748.152","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31133-4"},{"key":"2026061605251552000_16.6.e111748.153","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1161\/ATVBAHA.122.318020","article-title":"Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach","volume":"42","author":"Cofer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026061605251552000_16.6.e111748.154","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002034","article-title":"Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial)","volume":"4","author":"Grenon","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2026061605251552000_16.6.e111748.155","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201802445R"},{"key":"2026061605251552000_16.6.e111748.156","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2019.01.038"},{"key":"2026061605251552000_16.6.e111748.157","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000196729.98651.bf"},{"key":"2026061605251552000_16.6.e111748.158","doi-asserted-by":"crossref","first-page":"106944","DOI":"10.1016\/j.prostaglandins.2024.106944","article-title":"Exploring the unique role of specialized pro-resolving mediators in cancer therapeutics","volume":"178","author":"Quinlivan","year":"2025","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"2026061605251552000_16.6.e111748.159","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/ATVBAHA.120.315219","article-title":"Ambient Air Pollution and Atherosclerosis: Insights Into Dose, Time, and Mechanisms","volume":"41","author":"Bevan","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026061605251552000_16.6.e111748.160","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.07.099"},{"key":"2026061605251552000_16.6.e111748.161","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/cvr\/cvae082","article-title":"New insight into air pollution-related cardiovascular disease: an adverse outcome pathway framework of PM2.5-associated vascular calcification","volume":"120","author":"Ding","year":"2024","journal-title":"Cardiovasc Res"},{"key":"2026061605251552000_16.6.e111748.162","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3181dbece1"},{"key":"2026061605251552000_16.6.e111748.163","doi-asserted-by":"crossref","first-page":"33212","DOI":"10.1007\/s11356-024-33414-7","article-title":"The effect of indoor air filtration on biomarkers of inflammation and oxidative stress: a review and meta-analysis of randomized controlled trials","volume":"31","author":"Ren","year":"2024","journal-title":"Environ Sci Pollut Res Int"},{"key":"2026061605251552000_16.6.e111748.164","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000931"},{"key":"2026061605251552000_16.6.e111748.165","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00419-2016","article-title":"A joint ERS\/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical framework","volume":"49","author":"Thurston","year":"2017","journal-title":"Eur Respir J"},{"key":"2026061605251552000_16.6.e111748.166","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu458"},{"key":"2026061605251552000_16.6.e111748.167","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000679"},{"key":"2026061605251552000_16.6.e111748.168","doi-asserted-by":"crossref","unstructured":"Alexandre J , Cautela J , Ederhy S , et al . Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio\u2010Oncology Guidelines. JAHA 2020;9. doi:10.1161\/JAHA.120.018403","DOI":"10.1161\/JAHA.120.018403"},{"key":"2026061605251552000_16.6.e111748.169","doi-asserted-by":"crossref","unstructured":"Hernandez-Garcia E , Chrysikou E , Nekhlyudov L , et al . Home-built environment interventions and inflammation biomarkers: a systematic review and meta-analysis protocol. BJGP Open 2022;6. doi:10.3399\/BJGPO.2022.0104","DOI":"10.3399\/BJGPO.2022.0104"},{"key":"2026061605251552000_16.6.e111748.170","first-page":"234","article-title":"Implementing personalized pathways for cancer follow\u2010up care in the United States: Proceedings from an American Cancer Society\u2013American Society of Clinical Oncology summit","volume":"69","author":"Alfano","year":"2019","journal-title":"CA A Cancer J Clinicians"},{"key":"2026061605251552000_16.6.e111748.171","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.1941"},{"key":"2026061605251552000_16.6.e111748.172","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32345-0"},{"key":"2026061605251552000_16.6.e111748.173","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1470-2045(15)00062-5","article-title":"N-of-1 trials in oncology","volume":"16","author":"Collette","year":"2015","journal-title":"Lancet Oncol"},{"key":"2026061605251552000_16.6.e111748.174","doi-asserted-by":"crossref","first-page":"e1427","DOI":"10.1016\/S2214-109X(20)30343-0","article-title":"Adverse health effects associated with household air pollution: a systematic review, meta-analysis, and burden estimation study","volume":"8","author":"Lee","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2026061605251552000_16.6.e111748.175","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400182","article-title":"Source-Specific PM2.5 and Atherosclerotic Cardiovascular Disease Mortality","volume":"3","author":"Ma","year":"2024","journal-title":"NEJM Evid"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-111748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:26:04Z","timestamp":1781612764000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-111748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":175,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,16]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjopen-2025-111748"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-111748","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}